MindBio to Revolutionise Drug and Alcohol Testing in the Mining Industry using AI Voice-Based Drug & Alcohol Detection Solution

(TheNewswire)

• CEO Meets with Mining and Health Executives in SouthAmerica to discuss deployment of new drug and alcohol screeningsolution. 

• Mining deployment of the technology would disrupt drugand alcohol testing in the mining industry and represents a massiveglobal opportunity for the Company. 

• Voice activated solution would enable drug and alcoholscreening at the gate and at scale. 

Vancouver, British Columbia –TheNewswire - February 2, 2026 –MindBio Therapeutics Corp.(CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the“Company” or “MindBio”), abiotechnology company that conducts clinical health research and hasdeveloped a world first AI prediction tool for drug and alcoholintoxication detection by a simple analysis of the voice, is pleasedto announce its CEO, Justin Hanka has met with mining and healthexecutives in South America, to discuss potential deployment of theCompany’s technology into the mining industry.  

The Company has been showcasing its technology as anenterprise solution and has led to interest from mining and healthofficials in South America, who are interested in deploying theCompany’s intoxication technology “at the gate” as a first linescreen for multiple substances such as alcohol, hallucinogens,amphetamines, cocaine and cannabis.  

MindBio is investing heavily in developing itsproprietary drug and alcohol prediction technologies for use at scalein enterprise environments.  The platform technology in developmenthas wide applications particularly in employment situations, such asin the mining industry where broad screening for drug and alcoholintoxication in mining workers in South America is governmentmandated.  Alcohol and drug testing in the mining industry at scaleis currently slow, expensive, time consuming and personally invasive(ie. Involves collecting saliva, urine or blood samples plus breathtests).  Drug and alcohol testing is an essential aspect of ensuringthe health and safety of workers and preventing accidents that cancause massive delays and cost blow outs from a single avoidableaccident.  One accident can cost a mining company hundreds ofmillions in delayed production, site boycotts by unions, insurance andmedical expenses.

National workforce studies in Chile alone, show thatalcohol consumption among mining workers exceeds 75% and theproportion of problem drinkers is above 40% with drug use estimated in9% of the more than 200,000 mining workers in the country, (ACHS,2012: SENDA, 2024).  And internationally more than 20-25% of alloccupational accidents are directly or indirectly linked to substanceuse, (International Labour Organization 1996, 2022: Gomez et al,2002).  This translates to tens of thousands of preventable workplaceincidents related to drug and alcohol intoxication.

The Company’s core technology can reliably predictintoxication with hallucinogens and alcohol by analysing voice.  TheCompany plans to expand its algorithms to be able to detect otherprohibited drugs that are difficult to detect particularly at scaleand volume and require specialised equipment, with MindBio’ssolution provided by a simple analysis of the voice over itsproprietary AI platform.

The Company’s CEO Justin Hanka said, “We aredelighted by the commercial interest in our core technology by themining industry and will work with our counterparts in South Americato develop and deploy an appropriate solution for the region whichrepresents a massive opportunity for the Company to disrupt drug andalcohol testing  processes in the mining industry globally”.

For further information, please contact:

Justin Hanka, Chief ExecutiveOfficer

61 433140886

justin@mindbiotherapeutics.com

www.mindbiotherapeutics.com

About MindBio Therapeutics

MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6;OTCQB: MBQIF) is a biotechnology company headquartered in Vancouver,British Columbia, that for several years has been conducting drug andalcohol research and has created health prediction technologies usingAI and machine learning.  The Company has expertise in using speechanalytics as a prediction tool for drug and alcohol intoxication andhas created a world first voice and AI powered prediction model fordrug and alcohol intoxication for use in consumer and enterprisesituations.  The Company is developing a comprehensive enterpriseplatform using voice and powered by AI for use in detecting drug andalcohol intoxication in workplaces, law enforcement, mental health andtelehealth.

Cautionary Note ConcerningForward-Looking Statements:

The press release contains "forward-lookingstatements" within the meaning of applicable securities laws.Forward-looking statements can be identified by words such as:"anticipate," "intend," "plan,""budget," "believe," "project,""estimate," "expect," "scheduled,""forecast," "strategy," "future,""likely," "may," "to be,""could," "would," "should,""will" and similar references to future periods or thenegative or comparable terminology, as well as terms usually used inthe future and conditional. Forward-looking statements are based onassumptions as of the date they are provided. However, there can be noassurance that such assumptions will reflect the actual outcome ofsuch items or factors.

Additionally, there are known and unknown risk factorsthat could cause the Company's actual results and financialconditions to differ materially from those indicated in theforward-looking statements. Therefore, you should not rely on any ofthese forward-looking statements. Important risk factors that couldcause actual results and financial conditions to differ materiallyfrom those indicated in the forward-looking statements, include amongothers: general economic, market and business conditions in Canada andAustralia; market volatility; unforeseen delays in timelines for anyof the transactions or events described in this press release.  Allforward-looking information is qualified in its entirety by thiscautionary statement.

The Company disclaims any obligation to revise orupdate any such forward-looking statement or to publicly announce theresult of any revisions to any of the forward-looking informationcontained herein to reflect future results, events or developments,except as required by law.

Neither the Canadian Securities Exchange nor itsRegulation Service Provider (as that term is defined in the policiesof the Canadian Securities Exchange) accepts responsibility for theadequacy or accuracy of this release.

Copyright (c) 2026 TheNewswire - All rights reserved.